Identification |
Name: | Card-20(22)-enolide,3-[(6-deoxy-a-L-mannopyranosyl)oxy]-1,5,11,14,19-pentahydroxy-,hydrate (1:8), (1b,3b,5b,11a)- |
Synonyms: | Card-20(22)-enolide,3-[(6-deoxy-a-L-mannopyranosyl)oxy]-1,5,11,14,19-pentahydroxy-,octahydrate, (1b,3b,5b,11a)- (9CI); Ouabain octahydrate |
CAS: | 11018-89-6 |
EINECS: | 211-139-3 |
Molecular Formula: | C29H44 O12 . 8 H2 O |
Molecular Weight: | 584.6525 |
InChI: | InChI=1/C29H44O12/c1-13-22(34)23(35)24(36)25(40-13)41-15-8-19(32)28(12-30)21-17(3-5-27(28,37)9-15)29(38)6-4-16(14-7-20(33)39-11-14)26(29,2)10-18(21)31/h7,13,15-19,21-25,30-32,34-38H,3-6,8-12H2,1-2H3/t13-,15-,16+,17+,18+,19+,21?,22-,23+,24+,25-,26+,27-,28+,29-/m0/s1 |
Molecular Structure: |
|
Properties |
Transport: | UN 1544 6.1/PG 1 |
Melting Point: | 260 °C
|
Density: | 1.51 g/cm3 |
Refractive index: | 1.655 |
Solubility: | SLIGHTLY SOL IN WATER AT 20 DEG C, SOL IN HOT WATER SOL IN ALCOHOL |
Specification: | white to off-white crystalline powder usageEng:A cardiac glycoside that inhibits Na(+)/K(+) ATPase. It regulates transcription of MDR (increase, Pgp) and MRP (increase MRP1 and decrease CFTR, cyctic fibrosis transport receptor or cAMP-activated Cl- channel) genes, also alters localization of MRP1. Safety Statements:45 45:In case of accident or if you feel unwell, seek medical
advice immediately (show label where possible) |
Packinggroup: | III |
Color: | white |
Usage: | A cardiac glycoside that inhibits Na(+)/K(+) ATPase. It regulates transcription of MDR (increase, Pgp) and MRP (increase MRP1 and decrease CFTR, cyctic fibrosis transport receptor or cAMP-activated Cl- channel) genes, also alters localization of MRP1. |
Safety Data |
Hazard Symbols |
T: Toxic
|
|
|